Solventum (SOLV) CFO receives 35,321 RSUs and settles taxes with 2,786 shares

Rhea-AI Filing Summary

Solventum Corp Chief Financial Officer Wayde D. McMillan reported several equity-related transactions. On March 5, 2026, he acquired 35,321 Restricted Stock Units (RSUs) as a grant, each representing a right to receive 1 share of Class A Common Stock. These RSUs vest in three equal annual tranches on the first, second and third anniversaries of the grant date, subject to continued service.

On March 6, 2026, he exercised 8,802 RSUs, converting them into 8,802 shares of Common Stock at a stated price of $0.00 per share. The filing also shows a disposition of 2,786 shares of Common Stock at $69.41 per share in a tax-withholding transaction to satisfy obligations arising from the equity award. After these transactions, his directly held Common Stock position was 43,538 shares, and his directly held RSUs totaled 35,321 units.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McMillan Wayde D.

(Last) (First) (Middle)

2510 CONWAY AVENUE EAST

3M CENTER, BUILDING 275-6W

(Street)

MAPLEWOOD MN 55144

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Solventum Corp [ SOLV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/06/2026		M		8,802	A	$0	46,324	D
Common Stock	03/06/2026		F		2,786	D	$69.41	43,538	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/05/2026		A		35,321		(2)	(2)	Common Stock	35,321	$0	35,321	D
Restricted Stock Units	(1)	03/06/2026		M			8,802	(2)	(2)	Common Stock	8,802	$0	17,605	D

Explanation of Responses:

1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement.

2. The RSUs shall fully vest in three tranches, with one-third vesting on each of the first, second and third anniversaries of the grant date, subject to continued service through the vesting date.

Remarks:

	/s/Megan Bombick, attorney-in-fact for Wayde D. McMillan	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Solventum (SOLV) CFO Wayde D. McMillan report?

Solventum CFO Wayde D. McMillan reported an RSU grant, an RSU exercise, and a tax-related share disposition. He received 35,321 RSUs, converted 8,802 RSUs into common shares, and disposed of 2,786 shares to cover tax obligations tied to the equity award.

How many Restricted Stock Units were granted to the Solventum (SOLV) CFO?

The CFO received a grant of 35,321 Restricted Stock Units. Each RSU represents a contingent right to receive one share of Solventum’s Class A Common Stock upon settlement, providing equity-based compensation that aligns the executive’s interests with shareholders over the vesting period.

What are the vesting terms for the Solventum (SOLV) CFO’s new RSUs?

The 35,321 RSUs vest in three equal tranches over three years. One-third vests on each of the first, second, and third anniversaries of the grant date, conditioned on the CFO’s continued service with the company through each applicable vesting date.

Did the Solventum (SOLV) CFO sell shares in this Form 4 filing?

The filing shows a disposition of 2,786 shares coded as a tax-withholding transaction. Shares were delivered at $69.41 per share to satisfy tax liabilities related to the equity award, rather than representing an open-market discretionary share sale by the executive.

How many Solventum (SOLV) common shares does the CFO hold after these transactions?

Following the reported transactions, the CFO directly holds 43,538 shares of Solventum common stock. In addition, he directly holds 35,321 Restricted Stock Units, which may convert into shares in the future as the grants vest according to their three-year schedule.

What does the RSU exercise by the Solventum (SOLV) CFO involve?

The RSU exercise converted 8,802 Restricted Stock Units into 8,802 common shares at a stated price of $0.00. This reflects settlement of previously granted RSUs into actual stock, increasing the CFO’s share ownership while triggering associated tax obligations settled with share disposition.